Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lucy C Miller
Imatinib Mesylate for Plexiform Neurofibromas in Patients With Neurofibromatosis Type 1: A Phase 2 Trial
The Lancet Oncology
Oncology
Related publications
Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas
Multiple Plexiform Neurofibromas in Neurofibromatosis Type 1: A Case Report
Journal of Medical Science And clinical Research
Management of Head and Neck Plexiform Neurofibromas in Pediatric Patients With Neurofibromatosis Type 1
Archives of Otolaryngology–Head & Neck Surgery
Phase I Clinical Trial Combining Imatinib Mesylate and IL-2
OncoImmunology
Oncology
Allergy
Immunology
Hypervascular Neurofibromas in a Case of Neurofibromatosis Type 1 - A Case Report
Journal of Clinical and Experimental Dentistry
Dentistry
554 Sirolimus Gel Effectively Reduced Neurofibromas in Neurofibromatosis Type 1 in a Double-Blind, Placebo-Controlled, Randomized Clinical Trial
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Toward a Survey of Somatic Mutation of the NF1 Gene in Benign Neurofibromas of Patients With Neurofibromatosis Type 1
American Journal of Human Genetics
Genetics
Giant Plexiform Neurofibroma Causing Asymptomatic Cervical Spinal Cord Compression in a Child With Neurofibromatosis Type 1
BMJ Case Reports
Medicine
Craniofacial Plexiform Neurofibromatosis
Journal of Contemporary Dentistry
